Drug Topics October 18, 2024
Researchers explored the efficacy of Pfizer-BioNTech’s updated COVID-19 vaccine for the 2023-2024 period and its efficacy in improving various patient outcomes.
Researchers addressed the efficacy of COVID-19 vaccines that were approved for 2023-2024, finding that they continue to serve as the clinical standard for staying protected against the virus. The first COVID-19 vaccine approval came in August 2021 for Pfizer-BioNTech’s Comirnaty.1 Since then, updated vaccines have been necessary to keep the public protected against COVID-19 variants and the increase in cases during the winter seasons.
In posters presented at IDWeek 2024, researchers took a deep dive into COVID-19 vaccines approved for 2023-2024. Aside from exploring overall efficacy of the vaccine for protection against COVID-19, they also addressed its effects on...
Today's Sponsors
Today's Sponsor